Posttransplant cyclophosphamide versus anti-thymocyte globulin versus combination for graft-versus-host disease prevention in haploidentical transplantation for adult acute myeloid leukemia: A report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party.
Saved in:
| Title: | Posttransplant cyclophosphamide versus anti-thymocyte globulin versus combination for graft-versus-host disease prevention in haploidentical transplantation for adult acute myeloid leukemia: A report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party. |
|---|---|
| Authors: | Bazarbachi AH; EBMT Paris study office/CEREST-TC, Paris, France.; Department of Hematology, Saint Antoine Hospital, Paris, France.; INSERM UMR 938, Sorbonne University, Paris, France.; Division of Hematology/Oncology, Columbia University Irving Medical Center/New York-Presbyterian Hospital, New York, New York, USA., Labopin M; EBMT Paris study office/CEREST-TC, Paris, France.; Department of Hematology, Saint Antoine Hospital, Paris, France.; INSERM UMR 938, Sorbonne University, Paris, France., Raiola AM; Hematology and Cellular Therapy Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Blaise D; Transplantation and Cellular Immunotherapy Program, Department of Hematology, Institut Paoli Calmettes, MSC Lab, Aix Marseille University, Marseille, France., Arcese W; Stem Cell Transplant Unit, 'Tor Vergata' University of Rome, Policlinico Universitario Tor Vergata, Rome, Italy., Santarone S; Dipartimento Oncologico Ematologico, Terapia Intensiva Ematologica, Ospedale Civile, Pescara, Italy., Koc Y; Bone Marrow Transplant Unit, Medicana International Hospital Istanbul, Istanbul, Turkey., Bramanti S; Transplantation Unit Department of Oncology and Haematology, Istituto Clinico Humanitas, Milano, Italy., Kulagin A; RM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russia., Kwon M; Sección de Trasplante de Medula Osea, Hospital Gregorio Marañón, Madrid, Spain., Sica S; Universita Cattolica S. Cuore, Istituto di Ematologia, Rome, Italy., Sanz J; Hematology Department, Hospital Universitari i Politecnic La Fe, Instituto de Investigación Sanitaria La Fe, Valencia, CIBERONC, Instituto Carlos III, Madrid, Spain., Brissot E; EBMT Paris study office/CEREST-TC, Paris, France.; Department of Hematology, Saint Antoine Hospital, Paris, France.; INSERM UMR 938, Sorbonne University, Paris, France., Nagler A; Hematology and Bone Marrow Transplantation Division, Chaim Sheba Medical Center, Tel-Hashomer, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., Ciceri F; IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milano, Italy., Mohty M; EBMT Paris study office/CEREST-TC, Paris, France.; Department of Hematology, Saint Antoine Hospital, Paris, France.; INSERM UMR 938, Sorbonne University, Paris, France. |
| Source: | Cancer [Cancer] 2024 Sep 15; Vol. 130 (18), pp. 3123-3136. Date of Electronic Publication: 2024 May 17. |
| Publication Type: | Journal Article; Comparative Study |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1097-0142 |
|---|---|
| DOI: | 10.1002/cncr.35365 |
